← Evidence map

ArticlePharmaceuticals (Basel, Switzerland)2022

SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential Diagnosis.

Jakob Höppner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36297311